Get excellent grades in QAWI301 test with these Questions and Answers and braindumps

Our Business-Objects QAWI301 Questions and Answers with dumps questions are precise of the QAWI301 actual test. A total pool of QAWI301 PDF Questions is kept up with in an information base of inquiries. We add and update new Questions and Answers on the customary reasons for contenders to retain the most current substance.

Exam Code: QAWI301 Practice exam 2022 by Killexams.com team
QAWI301V3.0
Business-Objects QAWI301V3.0 health
Killexams : Business-Objects QAWI301V3.0 health - BingNews https://killexams.com/pass4sure/exam-detail/QAWI301 Search results Killexams : Business-Objects QAWI301V3.0 health - BingNews https://killexams.com/pass4sure/exam-detail/QAWI301 https://killexams.com/exam_list/Business-Objects Killexams : What on earth is that for? These bizarre objects are all health gadgets — but can you work out what they’re meant to treat? We review a selection

What on earth is that for? These bizarre objects are all health gadgets — but can you work out what they’re meant to treat? We review a selection

Genie's lamp that makes a splash

Nosebuddy, £17.99, mad-hq.com

This genie’s lamp-like device is a neti pot, used to flush out the sinuses and ease congestion. You fill it with sterile, salt water and, with a tilted head, you pour the water into one nostril — by tilting your head sideways, the water drains out the other nostril, bringing mucus that may have clogged the sinuses with it.

‘Neti pots can be helpful after a cold, during hay fever or to help sinus issues where a build-up of mucus in the nose can cause discomfort,’ says Professor Paul Chatrath, a consultant ear, nose and throat surgeon at Spire Hartswood Hospital in Essex. 

‘It flushes out congestion but also cleans the tiny hair cells in the nose, helping them start working effectively again.’

And it might reduce hospitalisation from Covid. A study published in August by the University of Georgia, U.S., looked at twice-daily nasal irrigation in 79 people with Covid and found it led to eight times fewer hospitalisations than the national average.

‘Nasal irrigation is effective, but you must use distilled or cooled boiled water to reduce the risk of contamination,’ says Professor Chatrath.

Red light laser fix 

Theradome, from £699, theradomeforhairloss.co.uk

It might look like a bicycle helmet, but Theradome is said to treat certain types of hair loss.

The helmet emits red light into the scalp that stimulates hair follicles, increasing the rate of hair growth in cases of hormone-related thinning. Use the helmet for 20 minutes twice a week.

‘Studies have shown that LLLT — low-level laser therapy — can stimulate hair growth,’ says Dr Anastasia Therianou, a consultant dermatologist and hair loss specialist at Imperial College Healthcare NHS Trust in London. ‘Large randomised controlled trials have demonstrated statistically significant re-growth by hair count [the number of hairs on the scalp] in both men and women after treatment.

‘However, more studies are needed to support efficacy.’

She adds: ‘It only works on some types of hair loss — specifically male and female pattern baldness, and it’s important that a diagnosis is made by a specialist before trying LLLT.

‘These devices should not be used by patients with skin cancers of the scalp or those who take certain antibiotics and diuretic medications.’

Drilling remedy 

Tvidler, from £29.95, tvidler.com

It looks like a drill tip made from flexible silicone but, in fact, Tvidler is meant to be used for cleaning wax from your ears.

The manufacturer claims it’s safer than using a cotton bud because it doesn’t push the wax further into the ear. Gently insert it into the ear canal using a clockwise motion.

‘I would not use it,’ says Professor Chatrath. ‘The conical design is based on a drill which pushes debris out — and that might work on soft wax. But I’d worry that if the wax was impacted some might be pushed the wrong way, which could make it worse. Ear wax is there for a reason — it protects and cleans the ear so, unless there’s a build-up affecting your hearing or causing you pain, it’s best left alone.

‘That said, you should also never use a cotton bud. If ear wax does bother you, speak to your GP. They will try wax-softening drops or refer you for microsuction.’

Padded hood 

Ostrich Pillow, £85, ostrichpillow.co.uk

Described as an ‘immersive pillow’, this padded hood is designed to help you sleep or nap when you’re on the go. The design blocks out light and noise (there’s a hole for your mouth and nose), while the padding makes it comfortable to rest your head on surfaces such as a desk or the tray table on a plane.

Sleep specialist Dr Neil Stanley says: ‘Humans are not designed to sleep upright — we’re supposed to take the pressure off our bodies when we sleep and, that combined with the fact that during dream sleep you lose muscle tone that makes your head loll, makes it difficult to get a good sleep on a plane — but this could help with that. I’d definitely try it if I was flying long-haul a lot.’

Heavy-handed kit 

Fingerweights, from £32, fingerweights.com

These tiny weights (10-30g each) are worn on the fingers to strengthen them or as part of rehabilitation in conditions such as stroke or arthritis.

Dr Rod Hughes, a consultant rheumatologist at Ashford and St Peter’s NHS Trust in Surrey, says: ‘If you have arthritis in the fingers, exercises to keep them flexible and the muscles around them strong is advisable. This can simply be grip-strength exercises using rubber balls.

‘This improves grip strength and adding weight may lead to greater improvements. The downside is these look fiddly, so may not be suitable if you have impaired hand and finger shape or function. Often, osteoarthritis results in extra new bone being formed with lumps around the finger joints. It’s unlikely to cause permanent harm but pressure on an already inflamed joint could make it uncomfortable.’

Sonic blaster 

The Y Brush, £108.99, y-brush.com

This mouthpiece has sonic bristles (which work like an electric toothbrush) that, it claims, can clean all of your teeth in ten seconds. A trial by the maker on 100 people found it removed 15 per cent more plaque than conventional brushing.

‘This has an interesting design but lacks robust evidence that we have for conventional toothbrushes,’ says Dr Praveen Sharma, a scientific adviser to the British Dental Association.

‘It’s one-size-fits-all and any dentist will tell you that having one mould to fit all jaws is virtually impossible.

‘By contrast conventional toothbrushes allow you to customise brushing to fit any mouth regardless of variations like gaps or size of teeth.’

Get hip and press this device into action 

Pso-rite, £79.99. pso-rite.co.uk

This plastic contraption is described as ‘the most revolutionary self-care mobility massage and muscle-release tool’.

You place the device on the floor, get into a press-up-like position over it, and press down so the points on each side poke into your hip bones on either side.

Doing this is said to massage a muscle called the psoas, which connects the lower back to the thigh bone. Some physiotherapists suggest tightness in this muscle is responsible for much back and hip pain.

Will Bateman, a physiotherapist at Surrey Physio, says: ‘The psoas is a very deep muscle. You can’t specifically stretch or work on it, much like you can’t feel it yourself. So while this product may provide the area a massage, it won’t target the psoas. On top of that, there’s some debate as to whether the psoas does cause all the pain that’s blamed upon it or whether disc problems or osteoarthritis of the hip are the triggers.

‘I’d rather patients spend their time doing dynamic stretching such as yoga to target all the muscles in this area than focusing on the psoas.’

Advertisement
Mon, 07 Nov 2022 09:18:00 -0600 text/html https://www.dailymail.co.uk/health/article-11400137/These-bizarre-objects-health-gadgets-work-theyre-meant-treat.html
Killexams : Elevance Health to Acquire BioPlus

INDIANAPOLIS--()--Elevance Health (NYSE: ELV) today announced that it has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners, to acquire BioPlus, a comprehensive specialty pharmacy. BioPlus provides a complete range of specialty pharmacy services for patients living with complex and chronic conditions, such as cancer, multiple sclerosis, hepatitis C, autoimmune diseases, and rheumatology. This acquisition will help Elevance Health meet the specialty drug needs of its clients and customers with a whole-health approach, supported by integrated programs across Elevance Health and Carelon, Elevance Health’s healthcare services brand.

“As a trusted, lifetime health partner, the acquisition of BioPlus helps us deliver on our whole-health strategy that gives our consumers improved access and reliability to their prescriptions when they need it most,” said Pete Haytaian, Executive Vice President, Elevance Health and President, Carelon. “In making BioPlus part of the Elevance Health family, we are committed to leveraging our resources to scale and broaden the reach of BioPlus’ best-in-class specialty pharmacy capabilities, delivering greater affordability and access to critical medications.”

The company will look to expand BioPlus’ speed and service models across more complex disease treatment areas to provide timely access to medication, deliver leading support services for both providers and patients, and ensure individuals receive distinctive clinical expertise and service at all levels of care.

BioPlus currently offers Centers of Excellence (CoEs), which address therapeutic areas such as oncology and multiple sclerosis, and Elevance Health will look to build out additional CoEs for therapeutic areas to serve consumers. CoEs include teams of specialized pharmacists and clinicians knowledgeable in therapeutics areas who partner with patients throughout their treatment journey. These services help ensure medication access, adherence, and high-quality health outcomes.

After the acquisition closes, the specialty pharmacy will operate as part of IngenioRx, Elevance Health’s pharmacy benefit manager within Carelon, Elevance Health’s healthcare services brand. BioPlus’ offerings will complement IngenioRx capabilities and will increase Elevance Health’s ability to provide end-to-end pharmacy services, act as a patient advocate for integrated services, and promote affordability.

After BioPlus is integrated into Elevance Health, consumers who receive both medical and pharmacy benefits from Elevance Health’s subsidiaries will benefit from the company’s ability to leverage medical and pharmacy data to deliver proactive, whole-health insights. Carelon will connect its businesses through its digital platform, so in situations where BioPlus’ pharmacy team identifies a patient who may need behavioral health support or in-home care services, that team will be able to seamlessly connect that patient to services to address their whole health needs.

The acquisition is subject to customary closing conditions and is expected to close in the first half of 2023. BioPlus is not expected to have a material impact on adjusted earnings per share in 2023.

About Elevance Health, Inc.

Elevance Health is a lifetime, trusted health partner fueled by its purpose to Improve the health of humanity. The company supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health’s companies serve more than 119 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on Twitter and Elevance Health on LinkedIn.

About CarepathRx

CarepathRx seeks to transform pharmacy care delivery for health systems and hospitals by delivering improved patient outcomes that drive clinical, quality, and financial results. Through an industry leading, comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx works to turn hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that aim to optimize pharmacy performance for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation, and new health system revenue streams. Today, CarepathRx serves more than 20 health systems and 600 hospitals, with more than 2,000 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

About Nautic

Nautic Partners, LLC (“Nautic”) is a middle-market private equity firm that focuses on three industries: healthcare, industrials, and services. Nautic has completed over 150 platform transactions throughout its 35-plus year history. Nautic's strategy is to partner with management teams to accelerate the growth trajectory of its portfolio companies via add-on acquisitions, targeted operating initiatives, and increased management team depth. For more information, please visit www.nautic.com.

Forward-Looking Statements

This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as “expect,” “feel,” “believe,” “will,” “may,” “should,” “anticipate,” “intend,” “estimate,” “project,” “forecast,” “plan” and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause genuine results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward- looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent otherwise required by federal securities laws, we do not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof. These risks and uncertainties include, but are not limited to: the impact of large scale medical emergencies, such as public health epidemics and pandemics, including COVID-19, and catastrophes; trends in healthcare costs and utilization rates; our ability to secure sufficient premium rates, including regulatory approval for and implementation of such rates; the impact of federal, state and international law and regulation, including changes in the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010, as amended; changes in economic and market conditions, as well as regulations that may negatively affect our liquidity and investment portfolios; our ability to contract with providers on cost-effective and competitive terms; competitive pressures and our ability to adapt to changes in the industry and develop and implement strategic growth opportunities; reduced enrollment; the impact of a cyber-attack or other cyber security breach resulting in unauthorized disclosure of member or employee sensitive or confidential information, including the impact and outcome of any investigations, inquiries, claims and litigation related thereto; risks and uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations imposed thereon; our ability to maintain and achieve improvement in Centers for Medicare and Medicaid Services Star ratings and other quality scores and funding risks with respect to revenue received from participation therein; a negative change in our healthcare product mix; costs and other liabilities associated with litigation, government investigations, audits or reviews; risks and uncertainties related to our pharmacy benefit management (“PBM”) business, including non-compliance by any party with the PBM services agreement between us and CaremarkPCS Health, L.L.C.; medical malpractice or professional liability claims or other risks related to healthcare and PBM services provided by our subsidiaries; general risks associated with mergers, acquisitions, joint ventures and strategic alliances; changes in tax laws; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; possible restrictions in the payment of dividends from our subsidiaries and increases in required minimum levels of capital; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; the potential negative effect from our substantial amount of outstanding indebtedness; a downgrade in our financial strength ratings; the effects of any negative publicity related to the health benefits industry in general or us in particular; failure to effectively maintain and modernize our information systems; events that may negatively affect our licenses with the Blue Cross and Blue Shield Association; intense competition to attract and retain employees; risks associated with our international operations; and various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations.

Wed, 09 Nov 2022 08:31:00 -0600 en text/html https://www.businesswire.com/news/home/20221108006310/en/Elevance-Health-to-Acquire-BioPlus
Killexams : A review of Mecklenburg County restaurant health inspections in October No result found, try new keyword!The Charlotte Business Journal is continuing ... chemicals and physical objects out of food. To see specifically what health inspectors look for when visiting a food establishment, check out ... Wed, 09 Nov 2022 21:31:00 -0600 text/html https://www.bizjournals.com/charlotte/news/2022/11/10/mecklenburg-county-restaurant-health-inspections.html Killexams : I Can’t Stop Buying (Actually Functional) Objects That Look Like Food

Photo-Illustration: The Strategist

A few years ago, I was at Russ & Daughters when I picked up a (now sadly discontinued) tin of “caviar” in royal blue. On further inspection, I realized that it wasn’t really caviar at all but delightful little mints shaped like caviar! What fun it was to whip these out of my purse at a party when someone inevitably asked for a mint. When I next stumbled across a barrette covered in shiny plastic pasta from a stall in Thailand, the same one-two-punch feeling of delight came over me — not only did this lovely thing keep my hair tidily styled, but it meant that I could finally wear pasta. In the years since, I’ve amassed what is now a pantry’s worth of functional objects that look like food.

One rule when it comes to buying these objets: they must be functional. While I understand the allure of marble fruit, I find it much more alluring when these trompe l’oeils actually do something. Here are some of my favorites.